Alphabet CFO discusses AI’s impact on breast cancer care at World Economic Forum

Michael Walter | | Radiology Business | Artificial Intelligence

At the World Economic Forum in Davos, Switzerland, Alphabet CFO Ruth Porat detailed the significant impact artificial intelligence (AI) technologies are having on breast cancer care.

According to a report from CNBC, Porat noted that less data is now required for AI to be effective. She also highlighted progress made at Google, which is owned by Alphabet, when it comes to distinguishing the difference between a slide with metastatic cancer and a slide without cancer.

“We needed only hundreds of biopsies from breast cancer patients—hundreds—in order to have a breakthrough in metastatic breast cancer because of the developments in AI,” she said.

Click below for the full story from CNBC.

Alphabet CFO: Our AI is so good we can detect breast cancer with less data than…

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Startup aiming to automate 90% of imaging workflows, creating an ‘AI radiology resident,’ raises $23M
ACR, top health systems form collaborative to help radiologists assess AI solutions
Radiology AI firm Mediaire raises nearly $12.7M in financing
RadNet stock surges 20% to all-time high following news of GE HealthCare partnership
Radiology AI vendor Volpara Health inks $7M Department of Defense contract
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
GE HealthCare moves PET/CT scanner production to United States

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.